GlassScriptPhysician profile
Brent K Hoke
NPI 1508884453
$9,251.54
in general payments reported to CMS, 2019-2025
41 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,330 · 2020: $758 · 2021: $1,263 · 2022: $1,784 · 2023: $1,570 · 2024: $1,215 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,115.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,332.26 | 2021-2025 | |
| Lilly USA, LLC | $1,126.85 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,002.84 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $878.64 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $783.38 | 2019-2025 | |
| Amgen INC. | $624.37 | 2019-2025 | Evenity, Prolia, Otezla |
| Merck Sharp & Dohme LLC | $569.32 | 2019-2025 | Gardasil 9, Belsomra, Capvaxive |
| Abbott Laboratories | $388.39 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Teva Pharmaceuticals USA, INC. | $240.86 | 2019-2024 | Ajovy, Austedo Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.27 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $174.39 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $158.76 | 2019-2024 | Xifaxan |
| Dexcom, INC. | $141.68 | 2022-2024 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $140.83 | 2019-2022 | |
| Radius Health, INC. | $130.31 | 2023-2025 | Tymlos |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Hoke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.